Symposium

The symposium is one of the main event in International Pharmaceutical Week (IPW) which will present various speakers from each focused theme, including educational and scientific symposium. The speakers are professionals from Indonesia and outside Indonesia. It is obligated for IPW’s participant to join this event and all participants are hoped to actively contribute during questions and answers session.

DETAILS

CLINICAL SYMPOSIUM 1

“Antibiotic Stewardship Program (ASP) in Hospital Setting and Multidisciplinary Team”

Mariyatul Qibtiyah, S.Si., SpFRS., Apt.
(dr. Soetomo Hospital, Indonesia)


Antimicrobial stewardship programs (ASP) in hospitals seek to optimize antimicrobial prescribing in order to improve individual patient care as well as reduce hospital costs and slow the spread of antimicrobial resistance. With antimicrobial resistance on the rise worldwide and few new agents in development, antimicrobial stewardship programs are more important than ever in ensuring the continued efficacy of available antimicrobials. The design of antimicrobial management programs should be based on the best current understanding of the relationship between antimicrobial use and resistance. Such programs should be administered by multidisciplinary teams composed of infectious diseases physicians, clinical pharmacists, clinical microbiologists, and infection control practitioners and should be actively supported by hospital administrators. The purpose of this lecture is to explain the implementation ASP in Indonesia’s hospital, to explain the roles of the pharmacist is ASP, and know how to develop a multidisciplinary team in ASP.

CLINICAL SYMPOSIUM 2

“Application of Natural Killer Cells for Cancer Treatment”

Dr. dr. Cosphiadi Irawan, SpPD-KHOM.*
(dr. Cipto Mangunkusumo National Central General Hospital)


Natural killer (NK) cells recognize targets stressed by malignant transformation or infection and can be long-lived. They become educated by interacting with major histocompatibility antigen (MHC) class I molecules to gain function to kill targets and produce cytokines. In the clinic, haploidentical NK cells can be adoptively transferred to treat cancer. The purposes of this lecture are to explain the basic research of NK cells and its implementation in cancer therapy.

CLINICAL SYMPOSIUM 3

“Pharmacist Specialization: An Advancement Towards Better Pharmacy Practice”

Prof. Dr. Syed Azhar Syed Sulaiman, B. Pharm., Pharm. D.
(Universiti Sains Malaysia, Malaysia)


Clinical pharmacists work directly with physicians, other health professionals, and patients to ensure that the medications prescribed for patients contribute to the best possible health outcomes. Clinical pharmacists practice in health care settings where they have frequent and regular interactions with physicians and other health professionals, contributing to better coordination of care. In these days, pharmacist specialist is one of the hot topic issues that clinical pharmacist talked about. The purposes of this symposium are to explain the implementation of 7-stars Pharmacist in pharmacist specialization, highlight the current issue of being pharmacist specialist, explain the development of pharmacist specialization, and identify future roles for pharmacist specialist in pharmacotherapy.

INDUSTRIAL SYMPOSIUM 1

“Development of Vaccine throughout Decades in Universal Coverage”

dr. Deliana Permatasari, MBA.*
(Chief Scientific Officer PT. Novartis Indonesia)


Vaccines have been one of the biggest success stories of modern medicine. WHO estimates that at least 10 million deaths were prevented between 2010 and 2015 thanks to vaccinations delivered around the world. Many millions of more lives were protected from the suffering and disability associated with diseases such as pneumonia, diarrhea, whooping cough, measles, and polio. In the era of sustainable development, immunization programmes have matured to the point that they can now serve as a model and a platform for delivering other priority public health interventions. This broadened role has been amply demonstrated by the global initiative to eradicate polio. The purpose of this lecture is to explain the importance of vaccine, development of vaccine, and process of discovering and creating of a vaccine.

INDUSTRIAL SYMPOSIUM 2

“Recombinant DNA Technology as Potential Novel Cancer Treatment”

Dr. Normala Abd. Latip
(Universoti Teknologi MARA, Malaysia)


In the past century, the recombinant DNA technology was just an imagination that desirable characteristics can be improved in the living bodies by controlling the expressions of target genes. However, in the recent era, this field has demonstrated unique impacts in bringing advancement in human life. Scientists can mass-produce monoclonal antibodies that are specifically targeted to chemical components of cancer cells. Refinements to these methods, using recombinant DNA technology, have improved the effectiveness and decreased the side effects of these treatments. The purpose of this lecture is to explain the development of novel cancer therapy and to understand the mechanism of Recombinant DNA to treat cancer.

INDUSTRIAL SYMPOSIUM 3

“The Advantage of Genetic Providing to Reach Effective and Efficient Pharmacotherapy”

Ahmad Rusdan Handoyo Utomo, Ph.D.*
(Laboratoty Consultant of Kalbe Genomics Laboratory)


Drug treatment is in many cases ineffective. Besides patients who do not respond to the treatment despite receiving expensive drugs, adverse drug reactions (ADRs) as a consequence of the treatment. Pharmacogenetics is the discipline which takes the patient’s genetic information of drug transporters, drug metabolizing enzymes, and drug receptors into account to allow for an individualized drug therapy leading to optimal choice and dose of the response of the drug by correlating gene expression or single-nucleotide polymorphisms with a drug’s efficacy or toxicity. The purpose of this lecture is to introduce pharmacogenetic treatment, to develop rational means to optimize drug therapy, with respect to the patient’s genotype, to ensure maximum efficacy with minimal adverse effects.

Leave a Reply